Flagship Pioneering Innovations Vi, LLC

Flagship Pioneering Innovations V, Inc.

Erica Gabrielle Weinstein

Avak Kahvejian

Morag Helen Stewart

Nicholas McCartney Plugis

Alexandra Sophie De Boer

Sebastian Trousil

Ki Young Paek

Catherine Cifuentes-Rojas

Kevin James Lebo

Fernando Martin Diaz

Simon Delagrave

Dhananjay Maniklal Nawandar

Ryan D Tedstone

Nathan Lawrence Yozwiak

Jared David Pitts

This invention relates generally to pharmaceutical compositions and preparations of circular polyribonucleotides and uses thereof.

Compositions comprising circular polyribonucleotides and uses thereof

This invention relates generally to viral vectors and viral particles based on Anelloviruses, which can be used to deliver an agent (e.g., an exogenous effector or an endogenous effector, e.g., a therapeutic effector) to a cell (e.g., a cell in a subject to be treated therapeutically). Described herein are anellosomes, anellovectors, and compositions and uses thereof.

Anellovirus compositions and methods of use

This invention relates generally to viral vectors and viral particles based on, which can be used to deliver an agent (e.g., an exogenous effector or an endogenous effector, e.g., a therapeutic effector) to a cell (e.g., a cell in a subject to be treated therapeutically). Described herein are anellosomes, anellovectors, and compositions and uses thereof.

Growing community of inventors

Boston, MA, United States of America

Erica Gabrielle Weinstein